Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRenishaw Regulatory News (RSW)

Share Price Information for Renishaw (RSW)

Share Price is delayed by 15 minutes
Get Live Data
5,390.00    -65.00 (-1.19%)
Bid:
5,410.00
Ask:
5,420.00
Spread: 10.00 (0.185%)
Market Cap: £3.92b
RSW Live PriceLast checked at - London Stock Exchange

Intraday Renishaw Share Chart

Interim Management Statement

14 Oct 2010 10:37

RNS Number : 3872U
Renishaw PLC
14 October 2010
 



 

 

Renishaw plc

Interim management statement

 

This statement has been prepared for the Group and relates to the three months ended 30th September 2010. It contains unaudited information that covers the first quarter and the period since.

 

Trading activity

 

I am pleased to report that the increased level of activity, reported in our trading statement on 9th September 2010, continues. Revenue for the three months to 30th September 2010 was a first quarter record £60.1m, an increase of 85% over the £32.5m achieved in the difficult first quarter of the previous year.

 

In the metrology sector, revenue was ahead by 91% at £57.0m, compared with £29.8m in the previous year, with significant growth across all product lines. The healthcare sector, still in the development stages for a number of the product lines, saw a 15% increase in revenue, from £2.7m last year to £3.1m this year.

 

Geographically, the Far East (mainly China) has experienced the highest growth over the comparable period last year, an increase of 117% over last year and now accounting for 42% of group revenue, compared with 35% last year.

 

Profit before tax for the first quarter amounted to £15.1m, compared with £2.0m last year. Revenue and profit before tax at the previous year's exchange rates benefited by £1.4m and £0.9m respectively.

 

The Group continues to invest heavily in its research and development programmes in both the metrology and healthcare sectors. Group headcount at the end of September 2010 was 2,207, up from 2,099 at 30th June 2010, the additional people primarily being taken on to support the increasing production and R&D activities.

 

Despite world economic uncertainties, current trends indicate a significant increase in group revenue and profit for the full year, although it is very early in the year to be confident that the current level of demand for the Group's products will be maintained.

 

Financial position, significant events and acquisitions

 

On 23rd July 2010, the Group acquired a 29% shareholding in Measurement Devices Limited (MDL) for the sum of £2.3m. MDL is a metrology company based in York, with offices in Aberdeen and USA (Houston). Its laser scanner products are primarily marketed in the areas of marine positioning and mine/quarry scanning. Whilst MDL's products will add to Renishaw's current range of laser-based products, MDL will also benefit from Renishaw's technology, engineering and manufacturing expertise and its worldwide distribution network.

 

On 3rd September 2010, the Group acquired a 51% shareholding in Diameter Limited for the sum of £0.3m. Diameter Limited specialises in diamond-like carbon coatings and shape memory alloys and has been a long-term supplier to the Company.

 

The Group continues to have a strong balance sheet with net cash balances at 30th September 2010 of £30.8m (30th June 2010 £31.1m).

 

I should like to thank our staff for their loyalty and how they have handled the rollercoaster ride over the last year, terminating in a very special effort, particularly by our manufacturing staff, that has made a major contribution to these results.

 

 

 

Sir David McMurtry CBE, RDI, FREng, CEng, FIMechE

Chairman and Chief Executive

 

14th October 2010

 

Renishaw plc

Registered office New Mills, Wotton-under-Edge, Gloucestershire, GL12 8JR

Registered number 1106260

Telephone number 01453 524524

Website www.renishaw.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSMIBLTMBJBMFM
Date   Source Headline
6th May 20267:00 amRNSTrading Statement
20th Apr 20267:00 amRNSTrading Statement
8th Apr 20267:00 amRNSBoard Changes
11th Feb 20267:00 amRNSHalf-year Financial Report
29th Jan 202612:00 pmRNSNotice of Half-year Results
28th Nov 202511:00 amRNSHolding(s) in Company
28th Nov 202511:00 amRNSHolding(s) in Company
27th Nov 20256:29 pmRNSHolding(s) in Company
27th Nov 20255:00 pmRNSDirector/PDMR Shareholding
26th Nov 20251:32 pmRNSResult of AGM
26th Nov 20258:30 amRNSShareholdings update
29th Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20254:00 pmRNSDirector/PDMR Shareholding
23rd Oct 20257:00 amRNSTrading Statement
21st Oct 20253:02 pmRNSVoting Arrangement
21st Oct 20253:00 pmRNSHolding(s) in Company
21st Oct 20253:00 pmRNSHolding(s) in Company
3rd Oct 20257:00 amRNSAnnual Financial Report
24th Sep 20257:00 amRNSDirector/PDMR Shareholding
23rd Sep 20257:00 amRNSNew reporting segments for FY2026
18th Sep 20257:00 amRNSFinal Results
21st Aug 20257:00 amRNSBoard Change and Trading Update
13th Aug 20257:00 amRNSDirectorate Change
17th Jun 20257:00 amRNSCapital Markets Day
8th May 20257:00 amRNSTrading Statement
14th Apr 20259:49 amRNSDirector/PDMR Shareholding
13th Feb 20257:00 amRNSHalf-year Report
9th Dec 20242:02 pmRNSDeath of Sir David McMurtry
27th Nov 20242:44 pmRNSResult of AGM
29th Oct 20241:28 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSTrading Statement
27th Sep 20247:15 amRNSAnnual Financial Report
12th Sep 20247:00 amRNSFinal Results
29th Aug 20242:00 pmRNSNotice of Results
1st Jul 20247:00 amRNSDirectorate Change
13th Jun 20247:00 amRNSDirectorate Change
16th May 20242:25 pmRNSAGM Voting Results Update Statement
8th May 20247:00 amRNSTrading Statement
2nd Apr 20245:19 pmRNSStatement regarding Renishaw plc
6th Feb 20247:00 amRNSHalf-year Report
30th Jan 202410:30 amRNSChange of Adviser
23rd Jan 20249:00 amRNSNotice of Half-year Results
29th Nov 20232:47 pmRNSResult of AGM
26th Oct 20237:00 amRNSTrading Statement
13th Oct 20237:00 amRNSNotice of AGM
3rd Oct 20237:00 amRNSAnnual Financial Report
19th Sep 20237:00 amRNSFinal Results
13th Sep 20237:00 amRNSRevised date for publication of results
21st Aug 20233:00 pmRNSDirectorate Change
12th Jul 20232:30 pmRNSVoting Arrangement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.